← brief for 2026-09-17 · Slowing decline

Clinical and Medication-Related Factors Associated with Adverse Renal Outcomes in Advanced Chronic Kidney Disease Patients Treated with Empagliflozin: A Real-World Study in Thailand

Article C Peer reviewed Observational

Key takeaways

This study followed people with advanced kidney disease who started taking empagliflozin. It looked at who had bad kidney outcomes after starting the drug. It is an observational study, so it shows a link, not proof of cause. The drug is known to be safe, but this study checks how it works in real life.

Who did this work

Ittaprach Yimsuk (Rangsit University) · Artitaya Vongsaroj (Nopparat Rajathanee Hospital) · Pikanet Suebchompoo (Rangsit University) · Adisorn Attarungrod (Rangsit University) · Alisa Yamba (Rangsit University) · Taniya Paiboonvong (Pathumthani University)

Source

Article · OpenAlex, CKD works · 2026-09-17
https://doi.org/10.3390/pharma5030035